Papakostas, George I.

Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation

McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 731

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 552

Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses

Sarris, J., Murphy, J., Mischoulon, D., Papakostas, G. I., Fava, M., Berk, M., & Ng, C. H. (2016) · American Journal of Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 436

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)

Fava, M., Freeman, M. P., Flynn, M., Judge, H., Hoeppner, B. B., Cusin, C., Ionescu, D. F., Mathew, S. J., Chang, L. C., Iosifescu, D. V., et al. (2020) · Molecular Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 433

Quality of life assessments in major depressive disorder: a review of the literature

Papakostas, G. I., Petersen, T., Mahal, Y., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2004) · General Hospital Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 331

Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 308

S -Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial

Papakostas, G. I., Mischoulon, D., Shyu, I., Alpert, J. E., & Fava, M. (2010) · American Journal of Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 297

A detailed examination of cytokine abnormalities in Major Depressive Disorder

Simon, N. M., McNamara, K., Chow, C. W., Maser, R. S., Papakostas, G. I., Pollack, M. H., Nierenberg, A. A., Fava, M., & Wong, K. K. (2008) · European Neuropsychopharmacology

Tryptophan and brain disordersTreatment of Major Depression

Cited by 286

l -Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials

Papakostas, G. I., Shelton, R. C., Zajecka, J. M., Etemad, B., Rickels, K., Clain, A., Baer, L., Dalton, E. D., Sacco, G. R., Schoenfeld, D., et al. (2012) · American Journal of Psychiatry

Treatment of Major DepressionFolate and B Vitamins Research

Cited by 275

Efficacy of Antidepressants for Late-Life Depression: A Meta-Analysis and Meta-Regression of Placebo-Controlled Randomized Trials

Tedeschini, E., Levkovitz, Y., Iovieno, N., Ameral, V. E., Nelson, J. C., & Papakostas, G. I. (2011) · The Journal of Clinical Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 269

A Cross-Sectional Study of the Prevalence of Cognitive and Physical Symptoms During Long-Term Antidepressant Treatment

Fava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006) · The Journal of Clinical Psychiatry

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 229

Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison

Heo, J.-Y., Kim, K., Fava, M., Mischoulon, D., Papakostas, G. I., Kim, M.-J., Kim, D. J., Chang, K.-A. J., Oh, Y., Yu, B.-H., et al. (2017) · Journal of Psychiatric Research

Circadian rhythm and melatoninSleep and Work-Related Fatigue

Cited by 192

Assessment of a Multi-Assay, Serum-Based Biological Diagnostic Test for Major Depressive Disorder: A Pilot and Replication Study

Papakostas, G. I., Shelton, R. C., Kinrys, G., Henry, M. E., Bakow, B. R., Lipkin, S. H., Pi, B., Thurmond, L., & Bilello, J. A. (2013) · Molecular Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 180

Effects of Psychiatric Disorders and Psychotropic Medications on Prolactin and Bone Metabolism

Misra, M., Papakostas, G. I., & Klibanski, A. (2004) · The Journal of Clinical Psychiatry

Bone health and osteoporosis researchSchizophrenia research and treatment

Cited by 156

Cognitive Symptoms in Patients With Major Depressive Disorder and Their Implications for Clinical Practice

Papakostas, G. I. (2014) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 153

Efficacy and Safety of Ketamine vs Electroconvulsive Therapy Among Patients With Major Depressive Episode: A Systematic Review and Meta-analysis

Rhee, T. G., Shim, S. R., Forester, B. P., Nierenberg, A. A., McIntyre, R. S., Papakostas, G. I., Krystal, J. H., Sanacora, G., & Wilkinson, S. T. (2022) · JAMA Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 141

Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis

Guidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011) · Psychological Medicine

Treatment of Major DepressionPsychotherapy Techniques and Applications

Cited by 118

Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

Papakostas, G. I., Petersen, T., Mischoulon, D., Ryan, J. L., Nierenberg, A. A., Bottiglieri, T., Rosenbaum, J. F., Alpert, J. E., & Fava, M. (2004) · The Journal of Clinical Psychiatry

Folate and B Vitamins ResearchTreatment of Major Depression

Cited by 113

Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis

Papakostas, G. I., Salloum, N. C., Hock, R. S., Jha, M. K., Murrough, J. W., Mathew, S. J., Iosifescu, D. V., & Fava, M. (2020) · The Journal of Clinical Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 108

Reduced orbitofrontal-thalamic functional connectivity related to suicidal ideation in patients with major depressive disorder

Kim, K., Kim, S.-W., Myung, W., Han, C. E., Fava, M., Mischoulon, D., Papakostas, G. I., Seo, S. W., Cho, H., Seong, J.-K., et al. (2017) · Scientific Reports

Functional Brain Connectivity StudiesTreatment of Major Depression

Cited by 107

Reduced frontal-subcortical white matter connectivity in association with suicidal ideation in major depressive disorder

Myung, W., Han, C. E., Fava, M., Mischoulon, D., Papakostas, G. I., Heo, J.-Y., Kim, K. W., Kim, S. T., Kim, D. J. H., Kim, D. K., et al. (2016) · Translational Psychiatry

Functional Brain Connectivity StudiesAdvanced Neuroimaging Techniques and Applications

Cited by 101

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators

Price, R. B., Kissel, N., Baumeister, A., Rohac, R., Woody, M. L., Ballard, E. D., Zarate, C. A., Deakin, W., Abdallah, C. G., Feder, A., et al. (2022) · Molecular Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 82

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

Papakostas, G. I., Nelson, J. C., Kasper, S., & Möller, H.-J. (2008) · European Neuropsychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 73

Elevated Cholesterol Levels Associated with Nonresponse to Fluoxetine Treatment in Major Depressive Disorder

Sonawalla, S. B., Papakostas, G. I., Petersen, T. J., Yeung, A. S., Smith, M. M., Sickinger, A. H., Gordon, J., Israel, J. A., Tedlow, J. R., Lamon-Fava, S., et al. (2002) · Psychosomatics

Treatment of Major DepressionLipoproteins and Cardiovascular Health

Cited by 62